Rh disease: Difference between revisions
From WikiMD's Wellness Encyclopedia
mNo edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
[[File: | | name = Rh disease | ||
| image = [[File:Blood_Type_Compatability.png|250px]] | |||
| caption = Blood type compatibility chart | |||
| synonyms = RhD hemolytic disease of the newborn, Rhesus isoimmunization | |||
| field = [[Obstetrics]], [[Pediatrics]] | |||
| symptoms = [[Jaundice]], [[anemia]], [[hepatosplenomegaly]], [[edema]] | |||
| complications = [[Kernicterus]], [[hydrops fetalis]], [[stillbirth]] | |||
| onset = During pregnancy or at birth | |||
| duration = Varies, can be chronic | |||
| causes = [[Rh incompatibility]] between mother and fetus | |||
| risks = Previous pregnancy with Rh+ baby, blood transfusion | |||
| diagnosis = [[Coombs test]], [[ultrasound]], [[amniocentesis]] | |||
| prevention = [[Rho(D) immune globulin]] administration | |||
| treatment = [[Phototherapy]], [[exchange transfusion]], [[intrauterine transfusion]] | |||
| frequency = Decreased significantly with preventive measures | |||
}} | |||
'''Rh disease''', also known as '''rhesus isoimmunisation''', '''Rh (D) disease''', '''rhesus incompatibility''', and several other names, is a form of [[hemolytic disease of the newborn (HDN)]]. This condition can manifest in varying degrees of severity and is particularly evident in certain subsequent pregnancies when an Rh-negative mother carries an Rh-positive fetus, a result of an Rh-positive father. | '''Rh disease''', also known as '''rhesus isoimmunisation''', '''Rh (D) disease''', '''rhesus incompatibility''', and several other names, is a form of [[hemolytic disease of the newborn (HDN)]]. This condition can manifest in varying degrees of severity and is particularly evident in certain subsequent pregnancies when an Rh-negative mother carries an Rh-positive fetus, a result of an Rh-positive father. | ||
[[File:Newborn_infant_with_severe_hemolytic_disease_(erythroblastosis_foetalis)_resulting_in_hydrops_foetalis.png|thumb|Newborn infant with severe Rhesus disease, suffering from [[hydrops fetalis]]|500px]]. | [[File:Newborn_infant_with_severe_hemolytic_disease_(erythroblastosis_foetalis)_resulting_in_hydrops_foetalis.png|thumb|Newborn infant with severe Rhesus disease, suffering from [[hydrops fetalis]]|500px]]. | ||
==Etiology== | ==Etiology== | ||
The disease arises primarily during the birth process, when the mother may come into contact with the infant's blood. Subsequent exposure can lead to the mother's immune system developing antibodies against the Rh factor in the fetus's blood. This immunological response can affect the health of subsequent Rh+ pregnancies. | The disease arises primarily during the birth process, when the mother may come into contact with the infant's blood. Subsequent exposure can lead to the mother's immune system developing antibodies against the Rh factor in the fetus's blood. This immunological response can affect the health of subsequent Rh+ pregnancies. | ||
<youtube> | <youtube> | ||
title='''{{PAGENAME}}''' | title='''{{PAGENAME}}''' | ||
| Line 19: | Line 31: | ||
height=600 | height=600 | ||
</youtube> | </youtube> | ||
==Symptoms and Progression== | ==Symptoms and Progression== | ||
In its milder forms, the fetus may experience only slight anemia accompanied by reticulocytosis. More pronounced cases can result in notable fetal anemia and erythroblastosis fetalis, another manifestation of HDN. In its most severe instances, Rh disease can precipitate [[hydrops fetalis]] or even stillbirth. | In its milder forms, the fetus may experience only slight anemia accompanied by reticulocytosis. More pronounced cases can result in notable fetal anemia and erythroblastosis fetalis, another manifestation of HDN. In its most severe instances, Rh disease can precipitate [[hydrops fetalis]] or even stillbirth. | ||
==Serology== | ==Serology== | ||
A small volume of fetal blood can enter the maternal circulation during pregnancy. If the mother's blood is Rh-negative and the baby's Rh-positive, the mother may produce antibodies against the rhesus D antigen on the baby's red blood cells. These antibodies, particularly IgG, can cross the placenta in this and subsequent pregnancies, and if present in sufficient quantities, can lead to the onset of Rh disease. This process can be seen as a form of diminished immune tolerance during pregnancy. Notably, the probability of Rh disease sensitization increases when the fetus and mother have compatible ABO blood types. | A small volume of fetal blood can enter the maternal circulation during pregnancy. If the mother's blood is Rh-negative and the baby's Rh-positive, the mother may produce antibodies against the rhesus D antigen on the baby's red blood cells. These antibodies, particularly IgG, can cross the placenta in this and subsequent pregnancies, and if present in sufficient quantities, can lead to the onset of Rh disease. This process can be seen as a form of diminished immune tolerance during pregnancy. Notably, the probability of Rh disease sensitization increases when the fetus and mother have compatible ABO blood types. | ||
==Diagnosis== | ==Diagnosis== | ||
* '''Maternal Blood''' | * '''Maternal Blood''' | ||
** [[Kleihauer–Betke test]] and flow cytometry can confirm fetal blood entry into maternal circulation and estimate its volume. | ** [[Kleihauer–Betke test]] and flow cytometry can confirm fetal blood entry into maternal circulation and estimate its volume. | ||
| Line 39: | Line 45: | ||
** A complete blood count provides important values such as hemoglobin and platelet count. | ** A complete blood count provides important values such as hemoglobin and platelet count. | ||
** Bilirubin, reticulocyte count, neutrophil count, thrombocyte count, ferritin, and others are assessed for a comprehensive diagnosis. | ** Bilirubin, reticulocyte count, neutrophil count, thrombocyte count, ferritin, and others are assessed for a comprehensive diagnosis. | ||
==Prevention== | ==Prevention== | ||
The majority of Rh disease instances can be preempted by treating the mother either during pregnancy or shortly after childbirth. Typically, an intramuscular injection of anti-RhD immunoglobulin (Rho(D) immune globulin) is administered to degrade any fetal rhesus D positive erythrocytes before the mother's immune system can identify and respond to them. | The majority of Rh disease instances can be preempted by treating the mother either during pregnancy or shortly after childbirth. Typically, an intramuscular injection of anti-RhD immunoglobulin (Rho(D) immune globulin) is administered to degrade any fetal rhesus D positive erythrocytes before the mother's immune system can identify and respond to them. | ||
==Modern Antenatal Care== | ==Modern Antenatal Care== | ||
== | == | ||
| Line 49: | Line 52: | ||
== | == | ||
Current antenatal protocols dictate that all Rh-negative pregnant women receive an anti-RhD IgG immunoglobulin injection around 28 weeks of gestation. This practice addresses the majority of sensitizing events which predominantly occur post the 28-week mark. | Current antenatal protocols dictate that all Rh-negative pregnant women receive an anti-RhD IgG immunoglobulin injection around 28 weeks of gestation. This practice addresses the majority of sensitizing events which predominantly occur post the 28-week mark. | ||
==Management== | ==Management== | ||
* '''Antenatal''' | * '''Antenatal''' | ||
** Ultrasound and Doppler examinations for early detection. | ** Ultrasound and Doppler examinations for early detection. | ||
| Line 59: | Line 60: | ||
** Phototherapy and exchange transfusion based on disease severity. | ** Phototherapy and exchange transfusion based on disease severity. | ||
** Use of IVIG for effective treatment and reduction in the need for other interventions. | ** Use of IVIG for effective treatment and reduction in the need for other interventions. | ||
==See Also== | ==See Also== | ||
* [[Hemolytic disease of the newborn]] | * [[Hemolytic disease of the newborn]] | ||
Latest revision as of 06:10, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Rh disease | |
|---|---|
| File:Blood Type Compatability.png | |
| Synonyms | RhD hemolytic disease of the newborn, Rhesus isoimmunization |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Jaundice, anemia, hepatosplenomegaly, edema |
| Complications | Kernicterus, hydrops fetalis, stillbirth |
| Onset | During pregnancy or at birth |
| Duration | Varies, can be chronic |
| Types | N/A |
| Causes | Rh incompatibility between mother and fetus |
| Risks | Previous pregnancy with Rh+ baby, blood transfusion |
| Diagnosis | Coombs test, ultrasound, amniocentesis |
| Differential diagnosis | N/A |
| Prevention | Rho(D) immune globulin administration |
| Treatment | Phototherapy, exchange transfusion, intrauterine transfusion |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Decreased significantly with preventive measures |
| Deaths | N/A |
Rh disease, also known as rhesus isoimmunisation, Rh (D) disease, rhesus incompatibility, and several other names, is a form of hemolytic disease of the newborn (HDN). This condition can manifest in varying degrees of severity and is particularly evident in certain subsequent pregnancies when an Rh-negative mother carries an Rh-positive fetus, a result of an Rh-positive father.
.
Etiology[edit]
The disease arises primarily during the birth process, when the mother may come into contact with the infant's blood. Subsequent exposure can lead to the mother's immune system developing antibodies against the Rh factor in the fetus's blood. This immunological response can affect the health of subsequent Rh+ pregnancies.
Symptoms and Progression[edit]
In its milder forms, the fetus may experience only slight anemia accompanied by reticulocytosis. More pronounced cases can result in notable fetal anemia and erythroblastosis fetalis, another manifestation of HDN. In its most severe instances, Rh disease can precipitate hydrops fetalis or even stillbirth.
Serology[edit]
A small volume of fetal blood can enter the maternal circulation during pregnancy. If the mother's blood is Rh-negative and the baby's Rh-positive, the mother may produce antibodies against the rhesus D antigen on the baby's red blood cells. These antibodies, particularly IgG, can cross the placenta in this and subsequent pregnancies, and if present in sufficient quantities, can lead to the onset of Rh disease. This process can be seen as a form of diminished immune tolerance during pregnancy. Notably, the probability of Rh disease sensitization increases when the fetus and mother have compatible ABO blood types.
Diagnosis[edit]
- Maternal Blood
- Kleihauer–Betke test and flow cytometry can confirm fetal blood entry into maternal circulation and estimate its volume.
- The indirect Coombs test identifies IgG antibodies potentially harmful to the fetus.
- Cell-free DNA testing can detect specific fetal DNA antigens non-invasively.
- Blood tests can determine the probability of the fetus inheriting particular antigens and the resultant risk of HDN.
- Fetal Blood (or Umbilical Cord Blood)
- Direct Coombs test checks for immune-mediated fetal anemia.
- A complete blood count provides important values such as hemoglobin and platelet count.
- Bilirubin, reticulocyte count, neutrophil count, thrombocyte count, ferritin, and others are assessed for a comprehensive diagnosis.
Prevention[edit]
The majority of Rh disease instances can be preempted by treating the mother either during pregnancy or shortly after childbirth. Typically, an intramuscular injection of anti-RhD immunoglobulin (Rho(D) immune globulin) is administered to degrade any fetal rhesus D positive erythrocytes before the mother's immune system can identify and respond to them.
Modern Antenatal Care[edit]
==
Heading text[edit]
==
Current antenatal protocols dictate that all Rh-negative pregnant women receive an anti-RhD IgG immunoglobulin injection around 28 weeks of gestation. This practice addresses the majority of sensitizing events which predominantly occur post the 28-week mark.
Management[edit]
- Antenatal
- Ultrasound and Doppler examinations for early detection.
- Intrauterine and intravascular blood transfusion methods.
- Early delivery considerations.
- Postnatal
- Phototherapy and exchange transfusion based on disease severity.
- Use of IVIG for effective treatment and reduction in the need for other interventions.
See Also[edit]
- Hemolytic disease of the newborn
- Rhesus factor
- Antenatal care
- Coombs test
- Hemolytic disease of the newborn
- Hemolytic anemia
- Hematology
- James Harrison: Australia's "Man With The Golden Arm"
External links[edit]
- National institute of Clinical Excellence (NICE) Guidelines for anti-D prophylaxis
- Summary of transfusion reactions in the US
 | |
|---|---|
 |
 |
| Conditions originating in the perinatal period / fetal disease | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
_resulting_in_hydrops_foetalis.png){kind=link}